MONTREAL (CN) - Conjuchem Biotechnologies claims that Allied Research International screwed up a test of a diabetes drug, PC:DAC-EXENDIN-4, overdosing some test patients and underdosing others, in San Antonio and Miami, wasting "precious patient resources" and endangering health. Conjuchem demands $7 million. See the superior court complaint.
Read the Top 8
Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.